Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab
| Title: | Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab |
|---|---|
| Authors: | Thor, Maria, Shepherd, Annemarie F., Preeshagul, Isabel, Offin, Michael, Gelblum, Daphna Y., Wu, Abraham J., Apte, Aditya, Simone, Charles B., II, Hellmann, Matthew D., Rimner, Andreas, Chaft, Jamie E., Gomez, Daniel R., Deasy, Joseph O., Shaverdian, Narek |
| Source: | In Radiotherapy and Oncology February 2022 167:158-164 |
| Database: | ScienceDirect |
| ISSN: | 01678140 |
|---|---|
| DOI: | 10.1016/j.radonc.2021.12.016 |
| Published in: | Radiotherapy and Oncology |
| Language: | English |